General Information
Revision date
2021-12-15
Product name
205-858-1
CAS No.
156-57-0
1.2.1 Relevant identified uses
Lunaphore Technologies SA
supplier name
Route de Lully 5C, CH-1131
Emergency telephone
+972 3-763-0639
Icons in SDS
Company Information
company name
Route de Lully 5C, CH-1131
e-mail address of the competent person responsible for the Safety Data Sheet
support-tech@lunaphore.com
GHS Information
Signal word
H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation
Hazard Codes
Hazard statements (CLP)
H302, H317, H319
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture Mono-constituent substance
Signal word
H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.
Precautionary statements
P280 - Wear protective gloves, protective clothing and eye or face protection. P261 - Avoid breathing dust. P264 - Wash hands thoroughly after handling.
Prevention
P362 + P364 - Take off contaminated clothing and wash it before reuse. P333 + P313 - If skin irritation or rash occurs Get medical advice or attention. P337 + P313 - If eye irritation persists Get medical advice or attention
Response
Not applicable.
Storage
Not applicable.
Disposal
mercaptamine hydrochloride
Hazardous Ingredients
Not applicable.
Supplemental label elements
elements Not applicable.
2.3 Other hazards
PBT P B T vPvB vP vB No N/A N/A N/A No N/A N/A : Product meets the criteria for PBT or vPvB according to Regulation (EC) No.
2.1 Classification of the substance or mixture
Mono-constituent substance Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Acute Tox. 4, H302 Eye Irrit. 2, H319 Skin Sens. 1A, H317 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
